We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Contribute a Review Article on Drug Metabolism

Drug Metabolism Reviews is the official journal of ISSX, the International Society for the Study of Xenobiotics, and has a 2017 impact factor of 4.450*.

Executive Editor, Anna Radominska-Pandya, is currently accepting submissions on an array of drug metabolism research. Drug Metabolism Reviews provides critically needed reviews-- covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species.

Additionally, Drug Metabolism Reviews offers new hypotheses of interest to diverse groups of medical professionals:

  • Enzymologists working in xenobiotic biotransformation
  • Pharmacologists
  • Toxicologists
  • Chemists
  • Microbiologists
  • Pharmacokineticists
  • Immunologists
  • Mass spectroscopists

*©2018 Clarivate Analytics, Journal Citation Reports®

Drug Metabolism Reviews

Table of Contents for Drug Metabolism Reviews. List of articles from both the latest and ahead of print issues.

Language: en-US

Publisher: Taylor & Francis

Visit Journal Articles

Submission guidelines

Review our Instructions for Authors site to ensure you have everything required to move through peer review, production and publication.

At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers.

When you are ready, you can submit through our online submission system.

Editorial information
Executive Editor : Anna Radominska-Pandya, University of Arkansas for Medical Sciences (RadominskaAnna@uams.edu)

Anna Radominska-Pandya

Meet the Executive Editor

Anna Radominska-Pandya received her Ph.D. from the Institute of Biochemistry and Biophysics at the Polish Academy of Sciences in Warsaw, Poland, and currently serves as a Professor in the Department of Biochemistry and Molecular Biology at UAMS in Little Rock, Arkansas. 

She has published 175 papers in various peer-reviewed journals, and has received 12 R01 grants from the NIH, all related to the regulation and suppression of human UGTs and their role as anti-proliferative agents in cancer models, the interactions between UGTs and cannabinoid receptors, the delivery of UGT genes and drugs into cancer cells using nanomaterials, and the roles of UGTs in the biotransformation of drugs including resveratrols and drugs of abuse such as marijuana and synthetic cannabinoids.
 

Latest Tweets